Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis

BACKGROUND: The emergence of genetically-modified human proteins and glucagon-like peptide-1 (GLP-1) receptor agonists have presented a promising strategy for effectively managing diabetes. Due to the scarcity of clinical trials focusing on the safety and efficacy of semaglutide as an adjunctive tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Tirath, Nageeta, Fnu, Sohail, Rohab, Butt, Tooba Shaukat, Ganesan, Shyamala, Madhurita, Fnu, Ahmed, Muhammad, Zafar, Mahrukh, Zafar, Wirda, Zaman, Mohammad Uzair, Varrassi, Giustino, Khatri, Mahima, Kumar, Satesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375936/
https://www.ncbi.nlm.nih.gov/pubmed/37498865
http://dx.doi.org/10.1080/07853890.2023.2239830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375936/
https://www.ncbi.nlm.nih.gov/pubmed/37498865
http://dx.doi.org/10.1080/07853890.2023.2239830

Ejemplares similares